bepecin bpc-157 clinical trial and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded The Hidden Risks of BPC‑157:
Description
A combination of a sodium channel-blocking drug and immunomodulating therapy may be more effective than either drug alone (59)

Liu H, McKenna LA, Dean MF

ANDREW HUBERMAN: Oh no, Im not saying that

Not for Specific Populations: Not intended for use by individuals under the age of 18
